Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05637697 · ClinicalTrials.gov registry record
Angelman Syndrome Video Assessment (ASVA) Source Material Study
A clinical trial, sponsored by The Emmes Company.
- Completed
- Registry status
- 73
- Enrollment target
NCT05637697 is a clinical trial that has completed, run by The Emmes Company. The registered enrollment target is 73 participants.
The verdict
NCT05637697 has completed, sponsored by The Emmes Company.
- COMPLETED
- Registry status
- 73 participants
- Enrollment target
Study Summary
This is a longitudinal, observational, nonrandomized, fully remote study enrolling approximately 55 participant-caregiver dyads. The study includes no treatments or interventions, and participants will not be asked to change their current treatments. The objective of this study is to gather sufficient source material videos to develop a scoring system for ASVA and to perform preliminary validation of that scoring system.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2021-08-31 |
| Est. Completion | 2023-08-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05637697
The ClinicalTrials.gov registry entry for NCT05637697 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Emmes Company, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05637697 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05637697 about?
NCT05637697 is a clinical study titled "Angelman Syndrome Video Assessment (ASVA) Source Material Study". This is a longitudinal, observational, nonrandomized, fully remote study enrolling approximately 55 participant-caregiver dyads. The study includes no treatments or interventions, and participants will not be asked to change their current treatments. The objective of this study is to gather sufficie...
What is the current status of trial NCT05637697?
This trial is currently completed. The enrollment target is 73 participants. The study started on 2021-08-31. Estimated completion is 2023-08-01.
Who is sponsoring clinical trial NCT05637697?
This trial is sponsored by The Emmes Company, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.